Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by CentreIce24on Aug 15, 2024 1:16pm
76 Views
Post# 36180937

RE:RE:TLRY / Medmen was back in 2021

RE:RE:TLRY / Medmen was back in 2021Did Irwin give you that talking point to post

The amount remaining on the books for Medmen is peanuts in comparison to annual net revenues of almost 800 million USD.
Yes he did, in the BNN interview
And which they have yet to acheive 

Remember shortly thereafter when he said 

Achieving $4B in Revenue

On a recent earnings call, Simon talked about the company’s goal to reach $4 billion in sales by 2024. Doubling its Canadian footprint and bringing its business in that market to $1 billion will be an integral part of achieving this goal. Tilray is also working to bring its European business to $1 billion. Growing its facilities in Germany and Portugal and leveraging its CC Pharma business will help to reach that point

And here we are 3 years later and they still haven't even acheived $1B in sales
The point is they spent $165M usd on Medmen only to receive $0 zero return
And what was their estimated run rate back in 2021 when the deal was made
Definetly wasn't close to $800M but rather approx $515M - $550M usd
So $165M usd back then out of approx 
$515M - $550M usd would be a big deal
I wouldn't say that is peanuts 
But then again this coming from a guy who touts you haven't lost any money if you don't sell even though the company no longer exists and/or went bankrupt

Please make it make sense

Have A Good Day
Cheers




<< Previous
Bullboard Posts
Next >>